You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Breast cancer

Gemcitabine for the treatment of metastatic breast cancer

  • Technology appraisal guidance
  • Reference number: TA116
  • Published:  24 January 2007
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Consultee and commentator comments on the ACD

  • Welsh Assembly Government

  • Southampton Health Technology Assessment Centre

  • Royal College of Radiologists

  • Royal College of Physicians

  • Royal College of Pathologists

  • Roche

  • National Collaborating Centre for Cancer

  • National Cancer Research Institute

  • Eli Lilly and Company Ltd

  • Department of Health

  • Cancerbackup

  • British Oncology Pharmacy Association

  • Breakthrough Breast Cancer


This page was last updated: 30 March 2010

Back to top